Calculating business valuation is not one formula. Institutional capital uses five methods, often in combination, and the realized valuation is the triangulation across them rather than the output of any single one. The arithmetic of each method is straightforward. The discipline is in the inputs and in how the five resolve into one defended range.
This article walks the five methods (trading comparables, transaction comparables, discounted cash flow, leveraged buyout returns, and asset-based), gives worked examples for the market-anchored and the intrinsic methods, and shows how the TEOL Valuation Calculator triangulates them into a defended range structured across the seven dimensions of the Capital Readiness Scorecard.
Calculating business valuation requires applying five methods in combination: trading comparables, transaction comparables, discounted cash flow, leveraged buyout returns, and asset-based. The triangulation across methods produces a defended range, not a single point estimate. The TEOL Valuation Calculator structures the read across the seven dimensions of the Capital Readiness Scorecard.
No single method produces the answer, because each measures something different. Trading comparables measure what the public market pays for similar earnings. Transaction comparables measure what acquirers have actually paid, control premium included. Discounted cash flow measures intrinsic worth independent of the market. The leveraged buyout method measures what a sponsor can afford. Asset-based valuation measures the floor. The realized valuation lives where the credible methods overlap, adjusted for the specific buyer's economics, the business's tranche fit, and the defended position of the seller. An operator who presents a single figure invites the buyer to discount it. An operator who presents a triangulated range, with each method shown and each input documented, presents a number the buyer has to argue against rather than simply mark down. The sections that follow calculate each method against the same illustrative $8M normalized EBITDA business, then resolve them into one defended range.
The five methods institutional capital uses to calculate business valuation, from trading and transaction comparables through discounted cash flow and leveraged buyout returns, triangulated into a defended range.
Apply the trading multiples of comparable public companies to the business's normalized EBITDA, adjusting for the size, growth, and liquidity differences between a public comparable and a lower-middle-market operator.
Apply the multiples paid in comparable precedent transactions, which include the control premium a buyer pays for outright ownership, and test the precedent set for genuine fit.
Project unlevered free cash flow, discount it at the weighted average cost of capital, and add the discounted terminal value to reach an intrinsic value independent of market comparables.
Solve for the entry multiple a financial sponsor can pay while still clearing its target internal rate of return given the available leverage and the projected exit.
Weight the methods by their relevance to the business and the likely buyer to produce a defended valuation range rather than a single point estimate.
The table below states what each method measures, the multiple or basis it produces in the lower middle market, and the businesses it is best applied to. The sections that follow calculate each one in turn.
| Method | What It Measures | Multiple or Basis | Best Applied To |
|---|---|---|---|
| Trading Comparables | Market value relative to public peers | 6.0x to 7.5x EBITDA | Sector-benchmarked operators with public peers |
| Transaction Comparables | Price paid in precedent acquisitions | 7.0x to 8.5x EBITDA | Businesses with genuine, recent precedent fit |
| Discounted Cash Flow | Intrinsic value of future cash flow | Variable | Predictable, contracted cash businesses |
| Leveraged Buyout Returns | Affordable entry multiple at target IRR | 5.5x to 6.5x EBITDA | Sponsor-fit businesses with leverage capacity |
| Asset-Based | Fair market value of net assets | NAV to 1.2x NAV | Capital-intensive, distressed, or liquidating |
Trading comparables apply the enterprise value to EBITDA multiples at which comparable public companies trade to the business's normalized EBITDA, then discount the public multiple for the size, growth, and liquidity differences between a listed company and a lower-middle-market operator. The output is a market-anchored range, not a single number.
The discipline is in two places. First, the comparable set: a peer is only comparable if it matches on sector, business model, and margin profile, and a peer chosen for a flattering multiple rather than genuine fit collapses in diligence. Second, the discount: a public company is larger, more liquid, and more diversified than a $40M to $80M business, so its multiple is reduced (commonly 20 to 35 percent) before it is applied. Skipping the discount is the most common error in this method, and it overstates the range by exactly the size of the omitted adjustment.
The 6.75x adjusted multiple applied to 8,000 of normalized EBITDA produces an implied enterprise value of 54,000, which anchors the trading-comparable candidate range at roughly $48M to $60M once the peer set is widened to a band rather than a single median. That range is the market read, and it is one of the five inputs the triangulation weighs.
Transaction comparables apply the multiples paid in comparable precedent acquisitions to the business's normalized EBITDA. These multiples include the control premium a buyer pays for outright ownership, which is why they sit above trading multiples. The Capital Readiness Scorecard reads precedent fit as a dimension of defensibility, because a mismatched precedent inflates the range and fails in diligence.
The control premium is the structural difference between this method and trading comparables. A trading multiple reflects a minority, liquid position. A transaction multiple reflects the purchase of the whole business and the control that comes with it, which a buyer typically pays 15 to 30 percent above the unaffected trading level to acquire. Applied to the $8M business, a transaction-comparable multiple of 7.0x to 8.5x produces a candidate range of roughly $56M to $68M.
Precedent fit is where this method is won or lost. A usable precedent set matches the subject business on size, sector, growth, and timing. A deal from a different cycle, a different size band, or a strategic buyer with unique synergies is not a precedent for a financial sale. The defended position is a small set of genuinely comparable, recent transactions with the rationale for each documented, so the buyer cannot dismiss the set as cherry-picked. The principle is developed further in the discussion of how capital tranches value a business, where the multiple a precedent carries depends on which tranche set it.
Discounted cash flow calculates intrinsic value by projecting unlevered free cash flow over an explicit forecast period, discounting each year at the weighted average cost of capital (WACC), and adding the discounted terminal value. The output is independent of market comparables. It is the most rigorous method and the most sensitive to its inputs, which is why it leads for predictable cash businesses and supports for volatile ones.
The build has four moving parts. The free cash flow projection sets the explicit-period cash. The WACC sets the discount rate, blending the cost of equity and the after-tax cost of debt at their respective weights. The terminal value captures the value beyond the forecast, calculated either on a perpetuity growth assumption or an exit multiple. The discounting then brings every future dollar back to present value. The terminal value usually carries the majority of the result, which is why a defensible terminal growth assumption matters as much as the forecast itself.
The discounted explicit-period cash flow of 17,500 plus the discounted terminal value of 39,000 produces an enterprise value of 56,500. Because the terminal value carries roughly 70 percent of that figure, a one-point change in WACC or a half-point change in terminal growth swings the result by several million dollars, which is why the DCF candidate range sits at $52M to $64M rather than a single point. The sensitivity is the reason DCF is triangulated against the market methods rather than relied on alone.
The leveraged buyout method solves for the entry multiple a financial sponsor can pay while still clearing its target internal rate of return (IRR), given the leverage available and the projected exit. It is a ceiling read on what a sponsor can afford, not an intrinsic read on what the business is worth. The output sets the negotiating floor when the likely buyer is a private equity add-on or platform.
The calculation works backward from the return. Start with the target IRR (commonly 20 to 25 percent over a five-year hold), the leverage available (often 3.0x to 4.0x EBITDA of debt), and the assumed exit multiple (typically the entry multiple held flat, with any improvement earned through growth rather than assumed). Solve for the highest entry multiple that still clears the IRR after debt paydown and the projected exit. For the $8M business, that backsolved entry multiple lands at roughly 5.5x to 6.5x, producing a candidate range of $44M to $52M.
The leveraged buyout output is lower than the strategic transaction range because a sponsor is not paying for synergy. It is paying for a financial return, and leverage plus IRR caps what the return can support. The defended position for a seller is to know this ceiling in advance, so a sponsor offer can be read against what the model can actually bear rather than against the seller's hope. The interaction between the entry multiple and the bridge to seller proceeds is covered in the EV-to-equity value bridge.
Asset-based valuation calculates the fair market value of net assets: tangible assets minus liabilities, with identifiable intangibles layered in where they apply. For a healthy going concern it produces the lowest of the five figures and serves as a floor, because the business earns more than the sum of its parts. It becomes the leading method only for capital-intensive, distressed, or liquidating businesses.
The calculation restates the balance sheet to fair market value rather than book value: property and equipment marked to current worth, inventory marked to net realizable value, receivables marked for collectability, and liabilities confirmed in full. The result is the net asset value (NAV). For the $8M business shown, the asset-based figure lands at $30M to $38M (NAV to 1.2x NAV), well below the earnings-based methods, which is exactly the signal that the business should be valued as a going concern rather than on its assets.
The use case determines the weight. A distribution business with a heavy fleet, a manufacturer with valuable real estate, or a business in distress where the earnings have failed are the situations where asset-based value governs. For most operating businesses it sits in the triangulation as a floor and a reasonableness check, confirming that the earnings-based range is the relevant one and that the buyer is paying for the business rather than the building.
Triangulating the five methods means weighting each by its relevance to the business and the likely buyer, then combining the weighted candidate ranges into a single defended range rather than reporting the highest figure. The TEOL Valuation Calculator structures this read across the seven dimensions of the Capital Readiness Scorecard, so the weighting is anchored to defensibility, not to optimism.
Calculate each of the five methods independently against the same normalized EBITDA and the same forecast, so the candidate ranges are comparable rather than built on different assumptions.
Discard the methods that do not fit the business: asset-based for a healthy going concern, transaction comparables where no genuine precedent exists, leveraged buyout where no sponsor is a plausible buyer.
Identify the most likely buyer tranche, because the buyer determines which method governs (a strategic acquirer anchors on transaction comparables, a sponsor on leveraged buyout returns).
Assign a weighting to each surviving method based on its relevance to the business and the likely buyer, with the weights summing to one hundred percent.
Combine the weighted candidate ranges into a single defended range, where the methods overlap rather than reporting the highest single figure.
Stress-test the range against the inputs a buyer substitutes in diligence, so the defended range is the one that survives a quality of earnings review rather than the one that looks best in a pitch.
| Method | Indicative Weighting | When It Leads (Use Case) |
|---|---|---|
| Trading Comparables | 25% | Sector-benchmarked operators with clear public peers |
| Transaction Comparables | 30% | Businesses with genuine, recent precedent fit |
| Discounted Cash Flow | 25% | Predictable, contracted cash businesses |
| Leveraged Buyout Returns | 15% | Sponsor-fit businesses with leverage capacity |
| Asset-Based | 5% | Capital-intensive, distressed, or liquidating businesses |
The diagram shows all five candidate ranges on a shared value axis. Selecting a method highlights its range and its convergence line into the defended bracket the five methods produce together. The bracket is the triangulated range a buyer has to argue against.
$48M to $60M
25%
Trading comparables apply the enterprise value to EBITDA multiples at which comparable public companies trade to the business's normalized EBITDA. The public multiple is never applied raw. A lower-middle-market operator is smaller, less liquid, and more concentrated than a listed peer, so the public multiple is discounted (commonly 20 to 35 percent) before it touches the earnings. The output is a market-anchored range, defensible because every input is observable.
Sector-benchmarked operators with clear public peers.
A defended valuation is not the highest of the five methods. It is the range where the credible methods overlap, weighted to the business and the likely buyer, and tested against the inputs a buyer substitutes in diligence. The Valuation Calculator runs the five methods against normalized EBITDA, weights them across the seven dimensions of the Capital Readiness Scorecard, and reports the triangulated range a counterparty would actually underwrite.
The range is only as good as the earnings underneath it, which is why the normalization is tested separately. The EBITDA Quality Calculator reads which add-backs survive a quality of earnings review, and the Sale Readiness Index reads whole-business diligence defense across the same dimensions. The full stack of methods, adjustments, and the bridge to seller proceeds is mapped in the pillar on how to value a business, with the small-business equivalent in how to value a small business.
Where the methods are tested hardest is in diligence, and the defense is built before the LOI. The work of preparing the comparable set, the model, and the normalized earnings is the subject of pre-transaction finance preparation, the defense of the range itself is covered in advanced M&A valuation concepts, and the input terms each method applies are defined in the glossary.
Five methods, weighted to the business and the likely buyer, resolve into one defended range. Run the methods before the buyer does, document each input, and present the number a counterparty has to argue against rather than simply mark down.